Dogs · Verified 2026-07-31

Dogs are behind cats, and the honest timeline is long.

There is no FDA-approved GLP-1 for dogs, and no canine GLP-1 trial has been announced. Dogs are named as the next species by the companies testing in cats, but no canine study has started. What is at the FDA for dogs is not a GLP-1 and not a weight-loss drug, and the one canine weight-loss drug ever approved was pulled from the market.

The canine programmes

Neither of these is a GLP-1. They are tracked because they are the regulatory and historical context readers most often mistake for one.

Pet GLP-1 and pet weight-loss drug programmes, grouped by how far each has progressed, with expected readout and regulatory status.
ProgrammeExpected readoutDetail
Not GLP-1sTracked as regulatory and historical context
LOY-002LoyalNot a GLP-1Company-projected launch before end of 2026Estimated, not company-confirmedFull status for LOY-002
Slentrol (dirlotapide)Pfizer Animal HealthNot a GLP-1Not applicableFull status for Slentrol (dirlotapide)

Nothing in this table is FDA-approved for weight loss in cats or dogs. A programme being in a pivotal study is not an approval, and an expected readout is not a result. Dates marked “estimated” come from reporting or analysis, not from the sponsor. Last verified 2026-07-31.

Read next

Nothing here is veterinary advice. Human GLP-1 medications cannot legally be prescribed for pets and are not safe to give them. Talk to your vet.